CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study

Por Stemmer, Salomon M., Benjaminov, Ofer, Medalia, Gal, Ciuraru, Noab B., Silverman, Michael H., Bar-Yehuda, Sara, Fishman, Sari, Harpaz, Zivit, Farbstein, Motti, Cohen, Shira, Patoka, Renana, Singer, Barak, Kerns, William D., Fishman, Pnina
Publicado em 2013

Treatment of Dry Eye Syndrome with Orally Administered CF101: Data from a Phase 2 Clinical Trial

Por Avni, Isaac, Garzozi, Hanna J., Barequet, Irina S., Segev, Fanni, Varssano, David, Sartani, Gil, Chetrit, Noa, Bakshi, Erez, Zadok, David, Tomkins, Oren, Litvin, Gilad, Jacobson, Kenneth A., Fishman, Sari, Harpaz, Zivit, Farbstein, Motti, Bar Yehuda, Sara, Silverman, Michael H., Kerns, William D., Bristol, David R., Cohn, Ilan, Fishman, Pnina
Publicado em 2010